Diagnosis and Treatment of Immune-Mediated Kidney Diseases
EP. 1: An overview of IgA Nephropathy
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN A panel of glomerular disease specialists provide an overview of immunoglobulin A nephropathy (IgAN).
EP. 2: IgA Nephropathy in Different Ethnic Populations
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Gerald B. Appel, MD discusses the prevalence of IgAN in various populations and the heterogeneity of the disease.
EP. 3: IgA Nephropathy in the Transplant Population
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Anuja Java, MD, discusses the heterogeneity of disease activity and recurrence in IgAN transplant population.
EP. 4: IgA Nephropathy in Pediatric Patients
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Carla M. Nester, MD, MSA, FASN, discusses the challenges of IgAN in pediatric patients.
EP. 5: An Overview of C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Carla M. Nester, MD, MSA, FASN, gives an overview of C3G.
EP. 6: C3G in Pediatric Patients
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Carla M. Nester, MD, MSA, FASN, discusses the differences of C3G in the pediatric versus adult population.
EP. 7: Challenges of Managing C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Anuja Java, MD, and Gerald B. Appel, MD, discuss the challenges of managing C3G in their patients.
EP. 8: Consequences of a Late or Missed Diagnosis of C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Anuja Java, MD; Carla M. Nester, MD, MSA, FASN; and Gerald B. Appel, MD, discuss the consequences of a missed or late diagnosis of C3G.
EP. 9: Differential Diagnosis of C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Anuja Java, MD, discusses the differential diagnosis of C3G.
EP. 10: The Pathology of IgAN on Kidney Biopsy
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Sanjeev Sethi, MD, discusses the role of the diagnostic kidney biopsy in IgAN.
EP. 11: The role of electro microscopy in the diagnosis of IgAN
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Sanjeev Sethi, MD, discusses the role of the electro microscopy in IgAN.
EP. 12: Kidney biopsy as a guide for treatment and prognosis
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Sanjeev Sethi, MD, and Gerald B. Appel, MD, discuss how the kidney biopsy can guide treatment and prognosis in IgAN.
EP. 13: Diagnostic testing in C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Anuja Java, MD, discusses the diagnostic tests that could lead to a diagnosis of C3G.
EP. 14: Diagnosing C3G in pediatric patients
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Carla M. Nester, MD, MSA, FASN, discusses the approach to diagnostic testing in pediatric patients suspected of C3G.
EP. 15: Kidney biopsy C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Sanjeev Sethi, MD, discusses the role of the diagnostic kidney biopsy in C3G.
EP. 16: Building expertise in C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN A panel of glomerular disease specialists discuss the importance of building centers of excellence with expertise on the pathology of C3G.
EP. 17: Clues to C3G in a biopsy
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Sanjeev Sethi, MD, discusses clues in the pathology of kidney biopsies that could lead to a C3G diagnosis.
EP. 18: Barriers to kidney biopsy
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Anuja Java, MD, discusses barriers to perform kidney biopsies to diagnose immune mediated kidney diseases in community settings.
EP. 19: Current standard of care for C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Carla M. Nester, MD, MSA, FASN discusses the current therapeutic area for C3G and what is on the horizon.
EP. 20: Clinical trial data on complement inhibition in C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Carla M. Nester, MD, MSA, FASN discusses recent clinical trials on complement inhibitors for C3G.
EP. 21: Complement therapy in transplant patients in C3G
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Anuja Java, MD, discusses the role of complement inhibitors in transplant patients with C3G.
EP. 22: Clinical trial data on IgAN for therapies
ByJonathan Barratt, PhD, FRCP,Gerald B. Appel, MD,Sanjeev Sethi, MD,Anuja Java, MD,Carla M. Nester, MD, MSA, FASN Gerald B. Appel, MD, discusses the changing treatment landscape of IgAN.
